{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "NAAT",
      "SARS-CoV-2 antigen",
      "bioanalysis",
      "clinical trials",
      "serology"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34374298",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "09",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "08",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.4155/bio-2021-0103"
    ],
    "Journal": {
      "ISSN": "1757-6199",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "15",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Bioanalysis",
      "ISOAbbreviation": "Bioanalysis"
    },
    "ArticleTitle": "COVID-19's impact on bioanalytical labs.",
    "Pagination": {
      "StartPage": "1169",
      "EndPage": "1171",
      "MedlinePgn": "1169-1171"
    },
    "Abstract": {
      "AbstractText": [
        "Tweetable abstract One year later, the impact of the COVID-19 pandemic on business practices, supply chains, timelines\u00a0and analytical needs for COVID-19 clinical trials have been felt across the bioanalytical community, as therapeutics may now require SARS-CoV-2 antigen and serological testing."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Immunochemistry R&D, PPD, 2244 Dabney Road, Richmond, VA\u00a023230, USA."
          }
        ],
        "LastName": "Lavelle",
        "ForeName": "Amy",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Immunochemistry R&D, PPD, 2244 Dabney Road, Richmond, VA\u00a023230, USA."
          }
        ],
        "LastName": "Micheli",
        "ForeName": "Janine",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Bioanalysis",
    "NlmUniqueID": "101512484",
    "ISSNLinking": "1757-6180"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Laboratories"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "\n<b>Financial & competing interests disclosure</b>\n. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript."
}